Economics
OPTN/SRTR 2016 Annual Data Report: Economics
Abstract
Medicare costs vary for solid organ transplant recipients by outcome: survival with graft function, survival with graft failure, and death. Average per-person per-year reimbursement was $75 thousand for kidney recipients who survived the first year posttransplant with a functioning graft, $171 thousand for those who required a return to dialysis or retransplant, and $350 thousand for those who died with function. For pancreas recipients: $105 thousand for those who survived the first year with a functioning graft, $120 thousand for those who survived pancreas failure, and $443 thousand for those who died with function. For liver recipients: $154 thousand for those who survived with a functioning graft, $388 thousand for those who required retransplant, and $740 thousand who died with function. For intestine recipients: $301 thousand for those who survived with a functioning graft and $1 million for those who died with function. For heart recipients: $272 thousand for those who survived with a functioning graft and $1.2 million for those who died with function. For lung recipients: $196 thousand for those who survived with a functioning graft, $642 thousand for those who required retransplant, and $761 thousand for those who died with function.
Introduction
SRTR continues to release new data for use in cost-effectiveness modeling and health economics and financial analysis in solid organ transplantation with this Annual Data Report. The cost impact of posttransplant outcomes is the subject of this year’s data expansion. Costs for recipients who survive with graft function, survive with graft failure, or die are presented separately for the first time. Future reports will continue to present these expanded data by outcome and we expect to present pretransplant costs separately for patients who do not undergo transplant separated by reason.
Kidney
From transplant through the first year posttransplant, the average reimbursement for kidney recipients with primary Medicare coverage at the time of transplant in 2008-2013 was $82 thousand (Table Econ 2). Average per-person per-year (PPPY) reimbursement for recipients who survived the first year posttransplant with a functioning graft was $75 thousand. This rose to $171 thousand for those who survived but required a return to dialysis or retransplant, 229% of the cost for those who ended the year alive with function. Average PPPY reimbursement for recipients who died with function in the first year was $350 thousand, 469% of the cost for those who ended the year alive with function. Average PPPY reimbursement for recipients who experienced graft failure and subsequently died was $506 thousand, 679% of the cost for those who ended the year alive with function. Patterns were similar in the second posttransplant year (Table Econ 3); however, relative costs were higher for recipients who died and/or experienced graft failure. Relative to $22 thousand average PPPY expenditure for recipients who were alive with function at the end of the second year, $84 thousand (389%) was spent on recipients who required a return to dialysis or retransplant, $84 thousand PPPY (589%) on those who died with function, and $201 thousand PPPY on those who died following graft failure.
Total Medicare reimbursement during the first year posttransplant was $4.6 billion (Table Econ 2). Of this, expenditures by outcome were $4.0 billion (86%) for recipients alive with a functioning graft, $321 million (6.9%) for those who survived but required a return to dialysis or retransplant, $246 million (5.3%) for those who died with function, and $81 million (1.7%) for those who died following graft failure. Proportions were: 93% of recipients alive with a functioning graft, 3.3% survived but required a return to dialysis or retransplant, 3.2% died with function, and 0.6% died following graft failure. Overall, the 7.1% of recipients who experienced death and/or graft failure within the first year posttransplant accounted for 14% of total costs. In contrast, the 7.7% of recipients who experienced death and/or graft failure within the second year posttransplant accounted for 24% of total costs (Table Econ 3). This was due primarily to increased proportions returning to dialysis or undergoing retransplant in the second year combined with their greater relative cost, thus accounting for 17% of total Medicare reimbursement in the second year.
Total Medicare expenditures in 2013 and 2014 for all kidney transplant recipients with graft function at the beginning of the year are presented in Table Econ 4 and Table Econ 5. Recipients with Medicare primary and/or secondary coverage are included in these tables if Medicare made any reimbursement for their care within the calendar year. Average PPPY and total Medicare reimbursement were $32 thousand and $4.1 billion in 2013 and $33 thousand and $4.2 billion in 2014. In each year, 2013 and 2014, 8.2% if recipients died and/or experienced graft failure, accounting for 17% of Medicare reimbursements. Compared with recipients in the second year posttransplant (Table Econ 3), PPPY costs averaged over 2013 and 2014 were 33% higher for those alive with function, 20% lower for those who required a return to dialysis or retransplant, 1% lower for those who died with function, and 18% lower for those who experienced graft failure followed by death.
Pancreas
From transplant through the first year posttransplant, the average reimbursement for pancreas recipients with primary Medicare coverage at the time of transplant in 2008-2013 was $110 thousand (Table Econ 7). Average per-person per-year (PPPY) reimbursement for recipients who survived the first year posttransplant with a functioning graft was $105 thousand. This rose to $120 thousand for recipients who survived pancreas failure, 115% of the cost for those who ended the year alive with graft function. Average PPPY reimbursement for recipients who died with function in the first year was $443 thousand, 423% of the cost for those who ended the year alive with function. Average per-patient costs in the second year posttransplant were $32 thousand, 35% less than the $49 thousand average cost in the year preceding transplant. Costs by outcome were much less in the second year posttransplant (Table Econ 8); however, relative costs were higher for recipients who died and/or experienced graft failure. Relative to $30 thousand average PPPY expenditure for recipients who were alive with function at the end of the second year, $59 thousand PPPY (195%) was spent on those who experienced pancreas failure, and $191 thousand PPPY (636%) on those who died with function.
Total Medicare reimbursement during the first year posttransplant was $318 million (Table Econ 7). Of this, expenditures by outcome were $270 million (85%) for recipients alive with a functioning graft, $32 million (10%) for those who survived pancreas failure, and $15 million (4.8%) for those who died with function. Proportions were: 87% of recipients alive with a functioning graft, 10% survived graft failure, and 3.0% died with function. Overall, the 13% of recipients who died and/or experienced graft failure within the first year posttransplant accounted for 15% of total costs. The 4.9% of recipients who died and/or experienced graft failure within the second year posttransplant accounted for 11% of total costs (Table Econ 8). Death with function accounted for 4.4% of costs, but only 1.4% of recipients, due to their relatively high cost.
Total Medicare expenditures in 2013 and 2014 for all pancreas transplant recipients with graft function at the beginning of the year for whom Medicare made any payment during the year are presented in Table Econ 9 and Table Econ 10. Average PPPY and total Medicare reimbursement were $32 thousand and $312 million in 2013 and $33 thousand and $322 million in 2014. In 2013, 6.4% of recipients died or and/or experienced graft failure, and 7.0% in 2014; these recipients accounted for 14% of Medicare reimbursement in 2013 and 15% in 2014. Compared with recipients in the second year posttransplant (Table Econ 8), PPPY costs averaged over 2013 and 2014 were 2.9% lower for those alive with function, 17% higher for those experiencing graft failure, and 31% lower for those who died with function.
Liver
From transplant through the first year posttransplant, the average reimbursement for liver recipients with primary Medicare coverage at the time of transplant in 2008-2013 was $185 thousand (Table Econ 12). Average per-person per-year (PPPY) reimbursement for recipients who survived the first year posttransplant with a functioning graft was $154 thousand. This rose to $388 thousand for recipients who required retransplant, 252% of the cost for those who ended the year alive with function. Average PPPY reimbursement for recipients who died with function in the first year was $740 thousand, 479% of the cost for those who ended the year alive with function. Costs were considerably less in the second year posttransplant (Table Econ 13). Average per-patient costs in the second year posttransplant were $28 thousand, 44% less than the $50 thousand average cost in the year preceding transplant. Relative to $25 thousand average PPPY expenditure for recipients who were alive with function at the end of the second year, $123 thousand (491%) was spent for those who required retransplant and $145 thousand (579%) for those who died with function.
Total Medicare reimbursement during the first year posttransplant was $1.2 billion (Table Econ 12). Of this, expenditures by outcome were $926 million (78%) for recipients who were alive with a functioning graft, $48 million (4.0%) for those who required retransplant, and $209 million (18%) for those who died with function. Proportions were: 86% alive with a functioning graft, 2.1% required retransplant, and 12% died with function. Overall, the 14% of recipients who died and/or experienced graft failure within the first posttransplant year accounted for 22% of total costs. The 6.2% of recipients who died and/or required retransplant within the second posttransplant year accounted for 16% of total costs (Table Econ 13).
Total Medicare expenditures in 2013 and 2014 for all liver transplant recipients with graft function at the beginning of the year are presented in Table Econ 14 and Table Econ 15. Recipients with Medicare primary and/or secondary coverage are included in these tables if Medicare made any reimbursement for their care within the calendar year. Average PPPY and total Medicare reimbursement were $26 thousand and $709 million in 2013 and $26 thousand and $739 million in 2014. In 2013, 6.9% of recipients died and/or required retransplant, accounting for 18% of Medicare reimbursement; in 2014 and 7.0% of such recipients accounted for 18% of Medicare reimbursement. Compared with recipients in the second year posttransplant (Table Econ 13), PPPY costs averaged over 2013 and 2014 were 11% lower for those alive with function, 61% higher for those who required retransplant, and 16% lower for those who died. Costs associated with retransplant in 2013 and 2014 averaged $197 thousand PPPY, 107% of costs for first transplant recipients between 2008 and 2013.
Intestine
From transplant through the first year posttransplant, the average per-person per-year (PPPY) reimbursement for intestine recipients with primary Medicare coverage at the time of transplant in 2008-2013 was $366 thousand and total reimbursement was $22 million (Table Econ 17). Average PPPY Medicare reimbursement was $301 thousand and total cost $15 million for the 70% of recipients who survived the first year posttransplant with a functioning graft. Average PPPY reimbursement rose to $1 million for recipients who died with function in the first year, 345% of the cost for those who ended the year alive with function, accounting for $5.8 million in total cost. Average per-patient costs in the second year posttransplant were $94 thousand, 28% less than the $130 thousand average cost in the year preceding transplant. Average PPPY cost in the second year posttransplant was $105 thousand and total cost was $4.1 million (Table Econ 18). Average cost was $88 thousand for recipients who survived the second year posttransplant, 84% of the average of all recipients.
Total Medicare expenditures in 2013 and 2014 for all Medicare-covered (primary or secondary) intestine transplant recipients with graft function at the beginning of the year are presented in Table Econ 19 and Table Econ 20. Average PPPY and total Medicare reimbursement were $60 thousand and $15 million in 2013 and $59 thousand and $15 million in 2014. In 2013, 13% of recipients died and/or experienced graft failure, accounting for 30% of Medicare reimbursement; in 2014, 15% of such recipients accounted for 31% of Medicare reimbursement. Compared with recipients in the second year posttransplant (Table Econ 18), PPPY costs averaged over 2013 and 2014 were 49% lower for those alive with function. Average PPPY Medicare reimbursement for recipients who died with function in 2013 or 2014 was $181 thousand.
Heart
From transplant through the first year posttransplant, the average per-person per-year (PPPY) reimbursement for heart recipients with primary Medicare coverage at the time of transplant in 2008-2013 was $305 thousand, and total reimbursement was $875 million (Table Econ 22). Average PPPY Medicare reimbursement was $272 thousand and total cost $753 million for the 88% of recipients who survived the first year posttransplant with a functioning graft. Average PPPY reimbursement rose to $1.2 million for recipients who died with function in the first year, 449% of the cost for those who ended the year alive with function and accounting for $122 million in total cost. Average PPPY cost in the second year posttransplant was $36 thousand and total cost was $78 million (Table Econ 23). Ninety-five percent of recipients survived the second year posttransplant with function, with an average PPPY cost of $32 thousand, 90% of the average of all recipients. Average per-patient costs in the second year posttransplant were $35 thousand, 69% less than the $112 thousand average cost in the year preceding transplant. During the second year posttransplant, 4.4% of recipients died with function at an average PPPY cost of $157 thousand and total cost of $7.1 million, 9.1% of total costs across all recipients.
Total Medicare expenditures in 2013 and 2014 for all Medicare-covered heart transplant recipients with graft function at the beginning of the year are presented in Table Econ 24 and Table Econ 25. Average and total Medicare reimbursement was $36 thousand and $464 million in 2013 and $37 thousand and $485 million in 2014. In 2013, 7.3% of recipients died and/or experienced graft failure, accounting for 15% of Medicare reimbursement; in 2014, and 7.7% of such recipients accounted for 16% of Medicare reimbursement.
Lung
From transplant through the first year posttransplant, the average per-person per-year (PPPY) reimbursement for lung recipients with primary Medicare coverage at the time of transplant in 2008-2013 was $239 thousand (Table Econ 27). Average PPPY reimbursement for recipients who survived the first year posttransplant with a functioning graft was $196 thousand. This rose to $642 thousand for recipients who required retransplant, 328% of the cost for those who ended the year alive with function. Average PPPY reimbursement for recipients who died with function in the first year was $761 thousand, 389% of the cost for those who ended the year alive with function. Costs were considerably less in the second year posttransplant (Table Econ 28). Average per-patient costs in the second year posttransplant were $49 thousand, 61% more than the $32 thousand average cost in the year preceding transplant. Relative to $41 thousand average PPPY expenditure for recipients who were alive with function at the end of the second year, $261 thousand PPPY (644%) was spent on those who required retransplant and $197 thousand PPPY (484%) on those who died with function.
Total Medicare reimbursement during the first year posttransplant for lung recipients was $674 million (Table Econ 27). Of this, expenditures by outcome were $510 million (76%) for those alive with a functioning graft, $20 million (3.0%) for those who required retransplant, and $145 million (21%) for those who died with function. Proportions were: 83% of recipients alive with a functioning graft, 1.7% required retransplant, and 15% died with function. Overall, the 17% of recipients died and/or experienced graft failure within the first year posttransplant, accounting for 24% of total costs. The 12% of recipients who died and/or required retransplant within the second year posttransplant accounted for 27% of total costs (Table Econ 28).
Total Medicare expenditures in 2013 and 2014 for all lung transplant recipients with graft function at the beginning of the year are presented in Table Econ 29 and Table Econ 30. Recipients with primary or secondary Medicare coverage are included in these tables if Medicare made at least one payment for their care within the calendar year. Average PPPY and total Medicare reimbursement were $49 thousand and $301 million in 2013 and $48 thousand and $309 million in 2014. In 2013, 12% of recipients died and/or required retransplant, accounting for 24% of Medicare reimbursement; in 2014, and 12% of such recipients accounted for 23% of Medicare reimbursement.
Figure List
Kidney
Figure Econ 1. Medicare coverage among kidney transplant recipients, 2008-2014
Pancreas
Figure Econ 2. Medicare coverage among pancreas transplant recipients, 2008-2014
Liver
Figure Econ 3. Medicare coverage among liver transplant recipients, 2008-2014
Intestine
Figure Econ 4. Medicare coverage among intestine transplant recipients, 2008-2014
Heart
Figure Econ 5. Medicare coverage among heart transplant recipients, 2008-2014
Lung
Figure Econ 6. Medicare coverage among lung transplant recipients, 2008-2014
Table List
Kidney
Table Econ 1. Average per person per year Medicare costs of kidney transplant recipients during the year prior to transplant
Table Econ 2. Total and per person per year Medicare costs of kidney transplant recipients in year 1 posttransplant
Table Econ 3. Total and per person per year Medicare costs of kidney transplant recipients in year 2 posttransplant
Table Econ 4. Total and per person per year (PPPY) calendar-year Medicare costs of kidney transplant recipients, 2013
Table Econ 5. Total and per person per year (PPPY) calendar-year Medicare costs of kidney transplant recipients, 2014
Pancreas
Table Econ 6. Average per person per year Medicare costs of pancreas transplant recipients during the year prior to transplant
Table Econ 7. Total and per person per year Medicare costs of pancreas transplant recipients in year 1 posttransplant
Table Econ 8. Total and per person per year Medicare costs of pancreas transplant recipients in year 2 posttransplant
Table Econ 9. Total and per person per year (PPPY) calendar-year Medicare costs of pancreas transplant recipients, 2013
Table Econ 10. Total and per person per year (PPPY) calendar-year Medicare costs of pancreas transplant recipients, 2014
Liver
Table Econ 11. Average per person per year Medicare costs of liver transplant recipients during the year prior to transplant
Table Econ 12. Total and per person per year Medicare costs of liver transplant recipients in year 1 posttransplant
Table Econ 13. Total and per person per year Medicare costs of liver transplant recipients in year 2 posttransplant
Table Econ 14. Total and per person per year (PPPY) calendar-year Medicare costs of liver transplant recipients, 2013
Table Econ 15. Total and per person per year (PPPY) calendar-year Medicare costs of liver transplant recipients, 2014
Intestine
Table Econ 16. Average per person per year Medicare costs of intestinal transplant recipients during the year prior to transplant
Table Econ 17. Total and per person per year Medicare costs of intestine transplant recipients in year 1 posttransplant
Table Econ 18. Total and per person per year Medicare costs of intestine transplant recipients in year 2 posttransplant
Table Econ 19. Total and per person per year (PPPY) calendar-year Medicare costs of intestine transplant recipients, 2013
Table Econ 20. Total and per person per year (PPPY) calendar-year Medicare costs of intestine transplant recipients, 2014
Heart
Table Econ 21. Average per person per year Medicare costs of heart transplant recipients during the year prior to transplant
Table Econ 22. Total and per person per year Medicare costs among heart transplant recipients in year 1 posttransplant
Table Econ 23. Total and per person per year Medicare costs among heart transplant recipients in year 2 posttransplant
Table Econ 24. Total and per person per year (PPPY) calendar-year Medicare costs of heart transplant recipients, 2013
Table Econ 25. Total and per person per year (PPPY) calendar-year Medicare costs of heart transplant recipients, 2014
Lung
Table Econ 26. Average per person per year Medicare costs of lung transplant recipients during the year prior to transplant
Table Econ 27. Total and per person per year Medicare costs of lung transplant recipients in year 1 posttransplant
Table Econ 28. Total and per person per year Medicare costs of lung transplant recipients in year 2 posttransplant
Table Econ 29. Total and per person per year (PPPY) calendar-year Medicare costs of lung transplant recipients, 2013
Table Econ 30. Total and per person per year (PPPY) calendar-year Medicare costs of lung transplant recipients, 2014
Table Econ 1 Average per person per year Medicare costs of kidney transplant recipients during the year prior to transplant Costs among recipients with Medicare as primary payer at the time of transplant, 2009-2014. Pretransplant costs exclude the transplant hospitalization. Per person per year (PPPY) costs in $ units. Values for cells with 9 or fewer recipients are suppressed. CKD, cystic kidney disease; GN, glomerulonephritis.
Subgroup | Patients, N | Pre-tx, 365 days | Pre-tx,90 days | Pre-tx, 30 days |
All recipients | 47,063 | 46,637 |
11,120 | 2861 | Age: 0-11
| 527 | 59,886 | 15,290 |
3555 | Age: 12-17 | 632 |
47,512 | 12,238 | 3216 |
Age: 18-34 | 5774 | 48,790 |
11,847 | 3050 | Age: 35-49
| 12,570 | 47,804 | 11,373 |
2908 | Age: 50-64 | 17,442 |
46,419 | 11,073 | 2872 |
Age: ≥65 | 10,118 | 43,587 |
10,184 | 2614 | Sex: Male
| 28,641 | 46,784 | 11,121 |
2841 | Sex: Female | 18,422 |
46,406 | 11,119 | 2890 |
Race/ethnicity: White | 21,827 | 44,365 |
10,776 | 2831 | Race/ethnicity: Black
| 14,523 | 50,016 | 11,619 |
2953 | Race/ethnicity: Hispanic | 7469 |
47,785 | 11,358 | 2896 |
Race/ethnicity: Asian | 2551 | 43,681 |
10,586 | 2522 | Race/ethnicity: Other/unknown
| 693 | 45,923 | 10,937 |
2713 | Diagnosis: Diabetes | 14,384 |
50,402 | 11,710 | 3026 |
Diagnosis: Hypertension | 12,119 | 45,055 |
10,414 | 2627 | Diagnosis: GN
| 7734 | 42,552 | 10,258 |
2608 | Diagnosis: CKD | 4808 |
42,015 | 10,134 | 2522 |
Diagnosis: Other | 8018 | 49,031 |
12,561 | 3363 |
Table Econ 2 Total and per person per year Medicare costs of kidney transplant recipients in year 1 posttransplant Costs for recipients with Medicare as primary payer at the time of transplant, 2008-2013. Year-1 costs include the transplant hospitalization. Costs incurred after a transplant failure are excluded. Total costs are given in $1000 units and per person per year (PPPY) costs in $ units. Values for cells with 9 or fewer recipients are suppressed. CKD, cystic kidney disease; GF, graft failure; GN, glomerulonephritis.
Subgroup | N | Total ($1000) | PPPY ($) |
All recipients | 57,279 | 4,626,193 |
82,470 | Age: 0-11 | 660 |
72,065 | 109,673 | Age: 12-17
| 812 | 71,751 | 88,309 |
Age: 18-34 | 7127 | 550,833 |
77,646 | Age: 35-49 | 15,383 |
1,198,850 | 78,882 | Age: 50-64
| 21,190 | 1,726,070 | 83,475 |
Age: ≥65 | 12,107 | 1,006,624 |
86,364 | Sex: Male | 34,951 |
2,808,280 | 82,080 | Sex: Female
| 22,328 | 1,817,913 | 83,083 |
Race/ethnicity: White | 26,723 | 2,141,587 |
81,987 | Race/ethnicity: Black | 17,591 |
1,500,212 | 87,036 | Race/ethnicity: Hispanic
| 9004 | 692,786 | 78,199 |
Race/ethnicity: Asian | 3113 | 230,388 |
75,485 | Race/ethnicity: Other/unknown | 848 |
61,219 | 74,127 | Diagnosis: Diabetes
| 17,282 | 1,518,663 | 90,588 |
Diagnosis: Hypertension | 14,838 | 1,141,946 |
78,594 | Diagnosis: GN | 9543 |
682,223 | 72,224 | Diagnosis: CKD
| 5837 | 424,629 | 73,599 |
Diagnosis: Other | 9779 | 858,732 |
89,587 | Outcome: Alive with function
| 53,201 | 3,977,905 | 74,567 |
Outcome: Dialysis/retransplant | 1879 | 321,296 |
170,526 | Outcome: Death with function | 1829 |
246,095 | 349,424 | Outcome: GF then death
| 370 | 80,899 | 506,240 |
Table Econ 3 Total and per person per year Medicare costs of kidney transplant recipients in year 2 posttransplant Costs for recipients with Medicare as primary payer at the time of transplant, 2008-2012. Year 2 is from day 366 to day 730 posttransplant. Costs incurred after transplant failure are excluded. Total costs are given in $1000 units and per person per year (PPPY) costs in $ units. Values for cells with 9 or fewer recipients are suppressed. CKD, cystic kidney disease; GF, graft failure; GN, glomerulonephritis.
Subgroup | N | Total ($1000) | PPPY ($) |
All recipients | 44,646 | 1,166,728 |
26,401 | Age: 0-11 | 534 |
15,865 | 29,628 | Age: 12-17
| 680 | 24,426 | 35,882 |
Age: 18-34 | 5801 | 152,109 |
26,275 | Age: 35-49 | 12,204 |
293,289 | 24,164 | Age: 50-64
| 16,242 | 430,271 | 26,818 |
Age: ≥65 | 9185 | 250,768 |
27,844 | Sex: Male | 27,090 |
685,705 | 25,603 | Sex: Female
| 17,556 | 481,022 | 27,627 |
Race/ethnicity: White | 20,952 | 534,414 |
25,808 | Race/ethnicity: Black | 13,704 |
392,504 | 28,926 | Race/ethnicity: Hispanic
| 6974 | 175,826 | 25,379 |
Race/ethnicity: Asian | 2359 | 48,641 |
20,818 | Race/ethnicity: Other/unknown | 657 |
15,343 | 23,517 | Diagnosis: Diabetes
| 13,170 | 415,973 | 32,031 |
Diagnosis: Hypertension | 11,681 | 289,760 |
25,088 | Diagnosis: GN | 7556 |
164,035 | 21,844 | Diagnosis: CKD
| 4550 | 99,034 | 21,893 |
Diagnosis: Other | 7689 | 197,927 |
25,960 | Outcome: Alive with function
| 41,196 | 891,110 | 21,572 |
Outcome: Dialysis/retransplant | 2327 | 196,036 |
84,014 | Outcome: Death with function | 876 |
53,731 | 127,048 | Outcome: GF then death
| 247 | 25,851 | 201,388 |
Table Econ 4 Total and per person per year (PPPY) calendar-year Medicare costs of kidney transplant recipients, 2013 Costs paid by Medicare in 2013 for recipients alive with graft function in 2013, regardless of Medicare eligibility at the time of transplant. Costs incurred after transplant failure are excluded. Total costs are given in $1000 units and per person per year (PPPY) costs in $ units. Values for cells with 9 or fewer recipients are suppressed. CKD, cystic kidney disease; GF, graft failure; GN, glomerulonephritis.
Subgroup | N | Total ($1000) | PPPY ($) |
All recipients | 136,150 | 4,085,889 |
32,340 | Age: 0-11 | 1623 |
69,469 | 45,743 | Age: 12-17
| 2684 | 124,231 | 48,586 |
Age: 18-34 | 21,733 | 781,778 |
37,679 | Age: 35-49 | 39,962 |
1,159,864 | 30,858 | Age: 50-64
| 51,041 | 1,378,222 | 29,308 |
Age: ≥65 | 19,107 | 572,325 |
33,858 | Sex: Male | 81,332 |
2,401,387 | 31,915 | Sex: Female
| 54,818 | 1,684,502 | 32,964 |
Race/ethnicity: White | 74,186 | 2,023,595 |
29,341 | Race/ethnicity: Black | 35,682 |
1,298,967 | 39,250 | Race/ethnicity: Hispanic
| 18,061 | 544,476 | 32,628 |
Race/ethnicity: Asian | 6603 | 170,741 |
28,060 | Race/ethnicity: Other/unknown | 1618 |
48,109 | 31,975 | Diagnosis: Diabetes
| 36,999 | 1,191,252 | 35,412 |
Diagnosis: Hypertension | 29,902 | 903,522 |
32,633 | Diagnosis: GN | 26,389 |
748,325 | 30,093 | Diagnosis: CKD
| 16,999 | 429,653 | 26,985 |
Diagnosis: Other | 25,861 | 813,136 |
33,565 | Outcome: Alive with function
| 125,028 | 3,383,923 | 28,433 |
Outcome: Dialysis/retransplant | 4021 | 260,270 |
66,612 | Outcome: Death with function | 6647 |
398,931 | 126,631 | Outcome: GF then death
| 454 | 42,765 | 159,170 |
Table Econ 5 Total and per person per year (PPPY) calendar-year Medicare costs of kidney transplant recipients, 2014 Costs paid by Medicare in 2014 for recipients alive with graft function in 2014, regardless of Medicare eligibility at the time of transplant. Costs incurred after transplant failure are excluded. Total costs are given in $1000 units and per person per year (PPPY) costs in $ units. Values for cells with 9 or fewer recipients are suppressed. CKD, cystic kidney disease; GF, graft failure; GN, glomerulonephritis.
Subgroup | N | Total ($1000) | PPPY ($) |
All recipients | 139,304 | 4,246,199 |
32,809 | Age: 0-11 | 1593 |
69,461 | 45,992 | Age: 12-17
| 2651 | 121,632 | 48,106 |
Age: 18-34 | 21,708 | 791,132 |
38,240 | Age: 35-49 | 40,493 |
1,206,846 | 31,651 | Age: 50-64
| 52,658 | 1,435,352 | 29,533 |
Age: ≥65 | 20,201 | 621,776 |
34,618 | Sex: Male | 83,258 |
2,501,487 | 32,437 | Sex: Female
| 56,046 | 1,744,712 | 33,358 |
Race/ethnicity: White | 75,254 | 2,093,819 |
29,865 | Race/ethnicity: Black | 36,668 |
1,345,134 | 39,593 | Race/ethnicity: Hispanic
| 18,766 | 567,122 | 32,591 |
Race/ethnicity: Asian | 6945 | 184,245 |
28,796 | Race/ethnicity: Other/unknown | 1671 |
55,880 | 36,377 | Diagnosis: Diabetes
| 38,108 | 1,255,732 | 36,107 |
Diagnosis: Hypertension | 30,567 | 928,961 |
32,777 | Diagnosis: GN | 26,805 |
782,480 | 31,016 | Diagnosis: CKD
| 17,492 | 438,761 | 26,721 |
Diagnosis: Other | 26,332 | 840,265 |
34,083 | Outcome: Alive with function
| 127,868 | 3,521,662 | 28,875 |
Outcome: Dialysis/retransplant | 3841 | 252,442 |
67,480 | Outcome: Death with function | 7151 |
427,890 | 123,676 | Outcome: GF then death
| 444 | 44,204 | 169,933 |
Table Econ 6 Average per person per year Medicare costs of pancreas transplant recipients during the year prior to transplant Costs among recipients with Medicare as primary payer at the time of transplant, 2009-2014. Pretransplant costs exclude the transplant hospitalization. Per person per year (PPPY) costs in $ units. Cohort includes pancreas transplants with and without kidney. Values for cells with 9 or fewer recipients are suppressed.
Subgroup | Patients, N | Pre-tx, 365 days | Pre-tx,90 days | Pre-tx, 30 days |
All recipients | 2211 | 48,959 |
11,728 | 3273 | Age: 0-11
| * | * | * | * |
Age: 12-17 | * | * |
* | * | Age: 18-34
| 535 | 58,816 | 14,008 |
4041 | Age: 35-49 | 1258 |
48,058 | 11,571 | 3170 |
Age: 50-64 | 407 | 39,450 |
9320 | 2591 | Age: ≥65
| 11 | 27,764 | 8245 | 2832 |
Sex: Male | 1376 | 48,359 |
11,406 | 3225 | Sex: Female
| 835 | 49,952 | 12,261 |
3352 | Race/ethnicity: White | 1392 |
44,585 | 10,733 | 3107 |
Race/ethnicity: Black | 479 | 60,162 |
14,049 | 3961 | Race/ethnicity: Hispanic
| 277 | 51,106 | 12,344 |
3092 | Race/ethnicity: Asian | 35 |
52,203 | 13,610 | 1987 |
Race/ethnicity: Other/unknown | 28 | 50,523 |
13,369 | 3155 | Diagnosis: Diabetes type 1
| 2003 | 48,715 | 11,672 |
3250 | Diagnosis: Diabetes type 2 | 208 |
51,320 | 12,273 | 3492 |
Diagnosis: Other/unknown | * | * |
* | * |
Table Econ 7 Total and per person per year Medicare costs of pancreas transplant recipients in year 1 posttransplant Costs for recipients with Medicare as primary payer at the time of transplant, 2008-2013. Year-1 costs include the transplant hospitalization. Costs incurred after transplant failure are excluded. Total costs are given in $1000 units and per person per year (PPPY) costs in $ units. Cohort includes pancreas transplants with and without kidney. Values for cells with 9 or fewer recipients are suppressed. GF, graft failure.
Subgroup | N | Total ($1000) | PPPY ($) |
All recipients | 2940 | 317,843 |
110,326 | Age: 0-11 | * |
* | * | Age: 12-17
| * | * | * |
Age: 18-34 | 696 | 77,441 |
112,882 | Age: 35-49 | 1669 |
173,814 | 106,106 | Age: 50-64
| 557 | 63,578 | 117,984 |
Age: ≥65 | 14 | 1858 |
133,568 | Sex: Male | 1856 |
191,793 | 105,374 | Sex: Female
| 1084 | 126,051 | 118,824 |
Race/ethnicity: White | 1852 | 195,685 |
108,236 | Race/ethnicity: Black | 633 |
72,211 | 115,263 | Race/ethnicity: Hispanic
| 378 | 40,705 | 109,266 |
Race/ethnicity: Asian | 46 | 5631 |
129,569 | Race/ethnicity: Other/unknown | 31 |
3612 | 118,316 | Diagnosis: Diabetes type 1
| 2458 | 259,864 | 107,703 |
Diagnosis: Diabetes type 2 | 240 | 24,637 |
104,384 | Diagnosis: Other/unknown | 242 |
33,342 | 143,628 |
Outcome: Alive with function | 2570 | 270,032 |
104,784 | Outcome: GF/Retransplant | 281 |
32,442 | 120,498 |
Outcome: Death with function | 89 | 15,370 |
443,299 |
Table Econ 8 Total and per person per year Medicare costs of pancreas transplant recipients in year 2 posttransplant Costs for recipients with Medicare as primary payer at the time of transplant, 2008-2012. Year 2 is from day 366 to day 730 posttransplant. Costs incurred after transplant failure are excluded. Total costs are given in $1000 units and per person per year (PPPY) costs in $ units. Cohort includes pancreas transplants with and without kidney. Values for cells with 9 or fewerrecipients are suppressed. GF, graft failure.
Subgroup | N | Total ($1000) | PPPY ($) |
All recipients | 2099 | 67,103 |
32,130 | Age: 0-11 | * |
* | * | Age: 12-17
| * | * | * |
Age: 18-34 | 506 | 18,777 |
37,048 | Age: 35-49 | 1179 |
35,186 | 29,967 | Age: 50-64
| 405 | 12,549 | 31,422 |
Age: ≥65 | * | * |
* | Sex: Male | 1321 |
37,664 | 28,622 | Sex: Female
| 778 | 29,439 | 38,104 |
Race/ethnicity: White | 1324 | 41,938 |
31,830 | Race/ethnicity: Black | 458 |
16,382 | 35,930 | Race/ethnicity: Hispanic
| 266 | 7248 | 27,367 |
Race/ethnicity: Asian | 27 | 806 |
30,871 | Race/ethnicity: Other/unknown | 24 |
730 | 30,317 | Diagnosis: Diabetes type 1
| 1755 | 55,412 | 31,718 |
Diagnosis: Diabetes type 2 | 170 | 4565 |
26,855 | Diagnosis: Other/unknown | 174 |
7127 | 41,558 | Outcome: Alive with function
| 1996 | 59,962 | 29,959 |
Outcome: GF/Retransplant | 73 | 4190 |
58,555 | Outcome: Death with function | 30 |
2951 | 190,686 |
Table Econ 9 Total and per person per year (PPPY) calendar-year Medicare costs of pancreas transplant recipients, 2013 Costs paid by Medicare in 2013 for recipients alive with graft function in 2013, regardless of Medicare eligibility at the time of transplant. Costs incurred after transplant failure are excluded. Total costs are given in $1000 units and per person per year (PPPY) costs in $ units. Cohort includes pancreas transplants with and without kidney. Values for cells with 9 or fewer recipients are suppressed. GF, graft failure.
Subgroup | N | Total ($1000) | PPPY ($) |
All recipients | 10,318 | 312,211 |
32,019 | Age: 0-11 | * |
* | * | Age: 12-17
| 11 | 641 | 63,096 |
Age: 18-34 | 2688 | 98,936 |
38,619 | Age: 35-49 | 5858 |
164,904 | 29,776 | Age: 50-64
| 1736 | 46,048 | 28,462 |
Age: ≥65 | 20 | 1218 |
66,739 | Sex: Male | 6203 |
175,704 | 30,042 | Sex: Female
| 4115 | 136,506 | 34,980 |
Race/ethnicity: White | 7802 | 221,738 |
29,956 | Race/ethnicity: Black | 1492 |
57,690 | 41,282 | Race/ethnicity: Hispanic
| 844 | 26,994 | 34,282 |
Race/ethnicity: Asian | 106 | 3667 |
38,375 | Race/ethnicity: Other/unknown | 74 |
2121 | 31,007 | Diagnosis: Diabetes type 1
| 8446 | 254,444 | 31,833 |
Diagnosis: Diabetes type 2 | 682 | 19,556 |
31,034 | Diagnosis: Other/unknown | 1190 |
38,211 | 33,876 |
Outcome: Alive with function | 9656 | 269,957 |
28,906 | Outcome: GF/Retransplant | 196 |
11,860 | 67,229 |
Outcome: Death with function | 466 | 30,394 |
129,069 |
Table Econ 10 Total and per person per year (PPPY) calendar-year Medicare costs of pancreas transplant recipients, 2014 Costs paid by Medicare in 2014 for recipients alive with graft function in 2014, regardless of Medicare eligibility at the time of transplant. Costs incurred after transplant failure are excluded. Total costs are given in $1000 units and per person per year (PPPY) costs in $ units. Cohort includes pancreas transplants with and without kidney. Values for cells with 9 or fewer recipients are suppressed. GF, graft failure.
Subgroup | N | Total ($1000) | PPPY ($) |
All recipients | 10,391 | 322,107 |
32,777 | Age: 0-11 | * |
* | * | Age: 12-17
| * | * | * |
Age: 18-34 | 2714 | 103,048 |
39,972 | Age: 35-49 | 5853 |
169,601 | 30,495 | Age: 50-64
| 1790 | 48,102 | 29,064 |
Age: ≥65 | 21 | 641 |
32,544 | Sex: Male | 6210 |
184,165 | 31,413 | Sex: Female
| 4181 | 137,942 | 34,792 |
Race/ethnicity: White | 7774 | 219,805 |
29,760 | Race/ethnicity: Black | 1555 |
67,368 | 46,461 | Race/ethnicity: Hispanic
| 875 | 29,246 | 35,683 |
Race/ethnicity: Asian | 118 | 4094 |
38,395 | Race/ethnicity: Other/unknown | 69 |
1593 | 24,384 | Diagnosis: Diabetes type 1
| 8521 | 259,429 | 32,156 |
Diagnosis: Diabetes type 2 | 694 | 23,512 |
36,503 | Diagnosis: Other/unknown | 1176 |
39,166 | 35,114 |
Outcome: Alive with function | 9661 | 274,817 |
29,285 | Outcome: GF/Retransplant | 214 |
13,218 | 69,906 |
Outcome: Death with function | 516 | 34,072 |
134,099 |
Table Econ 11 Average per person per year Medicare costs of liver transplant recipients during the year prior to transplant Costs among recipients with Medicare as primary payer at the time of transplant, 2009-2014. Pretransplant costs exclude the transplant hospitalization. Per person per year (PPPY) costs in $ units. Values for cells with 9 or fewer recipients are suppressed. ALD, alcoholic liver disease; HCC, hepatocellular carcinoma; HCV, hepatitis C virus.
Subgroup | Patients, N | Pre-tx, 365 days | Pre-tx,90 days | Pre-tx, 30 days |
All recipients | 5724 | 50,002 |
21,577 | 8273 | Age: 0-11
| 18 | 92,746 | 29,103 |
6557 | Age: 12-17 | * |
* | * | * |
Age: 18-34 | 143 | 53,554 |
21,879 | 8698 | Age: 35-49
| 656 | 58,695 | 25,762 |
9924 | Age: 50-64 | 2862 |
50,542 | 21,599 | 8284 |
Age: ≥65 | 2042 | 45,899 |
20,151 | 7723 | Sex: Male
| 3688 | 48,897 | 21,278 |
8252 | Sex: Female | 2036 |
52,011 | 22,122 | 8311 |
Race/ethnicity: White | 4002 | 48,865 |
21,206 | 8135 | Race/ethnicity: Black
| 584 | 51,882 | 21,339 |
8073 | Race/ethnicity: Hispanic | 844 |
55,855 | 24,467 | 9701 |
Race/ethnicity: Asian | 226 | 41,246 |
17,110 | 6376 | Race/ethnicity: Other/unknown
| 68 | 57,707 | 24,724 |
6716 | Diagnosis: Acute liver failure | 109 |
49,349 | 24,158 | 10,175 |
Diagnosis: HCV | 1601 | 53,707 |
23,452 | 8940 | Diagnosis: ALD
| 918 | 53,323 | 23,787 |
9386 | Diagnosis: Cholestatic disease | 410 |
48,071 | 21,276 | 8655 |
Diagnosis: HCC | 1136 | 37,234 |
13,885 | 5258 | Diagnosis: Other/unknown
| 1550 | 54,382 | 24,017 |
8899 | MELD: Status 1A/1B | 51 |
34,274 | 20,100 | 10,616 |
MELD: ≥ 35 | 960 | 62,751 |
34,832 | 13,972 | MELD: 30-34
| 895 | 57,961 | 27,819 |
10,775 | MELD: 15-29 | 3643 |
45,328 | 17,055 | 6319 |
MELD: < 15 | 173 | 43,669 |
13,800 | 4186 | MELD: Other/unknown
| * | * | * | * |
Table Econ 12 Total and per person per year Medicare costs of liver transplant recipients in year 1 posttransplant Costs for recipients with Medicare as primary payer at the time of transplant, 2008-2013. Year-1 costs include the transplant hospitalization. Costs incurred after transplant failure are excluded. Total costs are given in $1000 units and per person per year (PPPY) costs in $ units. Values for cells with 9 or fewer recipientss are suppressed. ALD, alcoholic liver disease; HCC, hepatocellular carcinoma; HCV, hepatitis C virus.
Subgroup | N | Total ($1000) | PPPY ($) |
All recipients | 6991 | 1,182,668 |
184,786 | Age: 0-11 | 22 |
5218 | 247,236 | Age: 12-17
| * | * | * |
Age: 18-34 | 172 | 31,553 |
195,996 | Age: 35-49 | 831 |
143,509 | 186,953 | Age: 50-64
| 3535 | 597,087 | 184,314 |
Age: ≥65 | 2427 | 404,702 |
183,291 | Sex: Male | 4533 |
759,616 | 182,762 | Sex: Female
| 2458 | 423,052 | 188,533 |
Race/ethnicity: White | 4882 | 799,692 |
179,231 | Race/ethnicity: Black | 716 |
131,525 | 200,275 | Race/ethnicity: Hispanic
| 1031 | 188,733 | 198,929 |
Race/ethnicity: Asian | 281 | 49,004 |
189,218 | Race/ethnicity: Other/unknown | 81 |
13,714 | 185,398 |
Diagnosis: Acute liver failure | 144 | 30,182 |
241,783 | Diagnosis: HCV | 1912 |
335,109 | 194,389 | Diagnosis: ALD
| 1138 | 198,402 | 186,049 |
Diagnosis: Cholestatic disease | 502 | 85,763 |
191,230 | Diagnosis: HCC | 1421 |
206,159 | 155,150 | Diagnosis: Other/unknown
| 1874 | 327,053 | 191,503 |
MELD: Status 1A/1B | 64 | 15,769 |
283,828 | MELD: ≥ 35 | 1082 |
263,823 | 282,193 | MELD: 30-34
| 1016 | 188,423 | 203,786 |
MELD: 15-29 | 4597 | 673,306 |
157,738 | MELD: < 15 | 228 |
40,488 | 190,431 | MELD: Other/unknown
| * | * | * |
Outcome: Alive with function | 5978 | 925,557 |
154,404 | Outcome: Retransplant | 149 |
47,838 | 388,392 |
Outcome: Death with function | 864 | 209,273 |
740,360 |
Table Econ 13 Total and per person per year Medicare costs of liver transplant recipients in year 2 posttransplant Costs for recipients with Medicare as primary payer at the time of transplant, 2008-2012. Year 2 is from day 366 to day 730 posttransplant. Costs incurred after transplant failure are excluded. Total costs are given in $1000 units and per person per year (PPPY) costs in $ units. Values for cells with 9 or fewer recipients are suppressed. ALD, alcoholic liver disease; HCC, hepatocellular carcinoma; HCV, hepatitis C virus.
Subgroup | N | Total ($1000) | PPPY ($) |
All recipients | 4829 | 134,626 |
28,698 | Age: 0-11 | 15 |
934 | 62,107 | Age: 12-17
| * | * | * |
Age: 18-34 | 125 | 3650 |
30,102 | Age: 35-49 | 598 |
16,400 | 28,029 | Age: 50-64
| 2488 | 72,661 | 29,978 |
Age: ≥65 | 1600 | 40,927 |
26,526 | Sex: Male | 3150 |
86,146 | 28,177 | Sex: Female
| 1679 | 48,480 | 29,672 |
Race/ethnicity: White | 3363 | 90,905 |
27,696 | Race/ethnicity: Black | 498 |
16,165 | 33,988 | Race/ethnicity: Hispanic
| 709 | 20,956 | 30,471 |
Race/ethnicity: Asian | 201 | 5595 |
29,657 | Race/ethnicity: Other/unknown | 58 |
1006 | 17,659 |
Diagnosis: Acute liver failure | 94 | 2483 |
27,327 | Diagnosis: HCV | 1279 |
37,084 | 29,990 | Diagnosis: ALD
| 795 | 21,560 | 27,716 |
Diagnosis: Cholestatic disease | 343 | 9857 |
29,610 | Diagnosis: HCC | 1020 |
28,644 | 29,298 | Diagnosis: Other/unknown
| 1298 | 34,999 | 27,444 |
MELD: Status 1A/1B | 44 | 1283 |
29,462 | MELD: ≥ 35 | 649 |
19,155 | 30,489 | MELD: 30-34
| 673 | 21,119 | 32,549 |
MELD: 15-29 | 3296 | 87,368 |
27,246 | MELD: < 15 | 163 |
5522 | 34,529 | MELD: Other/unknown
| * | * | * |
Outcome: Alive with function | 4529 | 113,394 |
24,969 | Outcome: Retransplant | 20 |
2402 | 122,588 | Outcome: Death with function
| 280 | 18,830 | 144,650 |
Table Econ 14 Total and per person per year (PPPY) calendar-year Medicare costs of liver transplant recipients, 2013 Costs paid by Medicare in 2013 for recipients alive with graft function in 2013, regardless of Medicare eligibility at the time of transplant. Costs incurred after transplant failure are excluded. Total costs are given in $1000 units and per person per year (PPPY) costs in $ units. Values for cells with 9 or fewer recipients are suppressed. ALD, alcoholic liver disease; HCC, hepatocellular carcinoma; HCV, hepatitis C virus.
Subgroup | N | Total ($1000) | PPPY ($) |
All recipients | 29,144 | 709,085 |
26,143 | Age: 0-11 | 134 |
4930 | 38,248 | Age: 12-17
| 102 | 2637 | 26,466 |
Age: 18-34 | 1087 | 26,073 |
24,974 | Age: 35-49 | 6252 |
136,546 | 22,966 | Age: 50-64
| 17,130 | 388,618 | 24,248 |
Age: ≥65 | 4439 | 150,281 |
38,750 | Sex: Male | 19,003 |
451,349 | 25,526 | Sex: Female
| 10,141 | 257,736 | 27,298 |
Race/ethnicity: White | 21,866 | 511,400 |
25,085 | Race/ethnicity: Black | 2363 |
70,842 | 32,653 | Race/ethnicity: Hispanic
| 3540 | 95,493 | 29,151 |
Race/ethnicity: Asian | 1113 | 24,420 |
23,351 | Race/ethnicity: Other/unknown | 262 |
6929 | 28,271 |
Diagnosis: Acute liver failure | 1199 | 22,990 |
19,957 | Diagnosis: HCV | 7287 |
184,782 | 27,412 | Diagnosis: ALD
| 5656 | 131,693 | 24,983 |
Diagnosis: Cholestatic disease | 3222 | 69,007 |
22,528 | Diagnosis: HCC | 3382 |
82,592 | 27,135 | Diagnosis: Other/unknown
| 8398 | 218,022 | 27,766 |
MELD: Status 1A/1B | 1331 | 24,687 |
19,275 | MELD: ≥ 35 | 2985 |
110,601 | 41,383 | MELD: 30-34
| 2598 | 76,395 | 32,607 |
MELD: 15-29 | 14,420 | 327,262 |
24,465 | MELD: < 15 | 1345 |
32,836 | 25,511 | MELD: Other/unknown
| 6465 | 137,303 | 22,280 |
Outcome: Alive with function | 27,138 | 581,871 |
22,244 | Outcome: Retransplant | 108 |
17,962 | 207,633 |
Outcome: Death with function | 1898 | 109,252 |
124,513 |
Table Econ 15 Total and per person per year (PPPY) calendar-year Medicare costs of liver transplant recipients, 2014 Costs paid by Medicare in 2014 for recipients alive with graft function in 2014, regardless of Medicare eligibility at the time of transplant. Costs incurred after transplant failure are excluded. Total costs are given in $1000 units and per person per year (PPPY) costs in $ units. Values for cells with 9 or fewer recipients are suppressed. ALD, alcoholic liver disease; HCC, hepatocellular carcinoma; HCV, hepatitis C virus.
Subgroup | N | Total ($1000) | PPPY ($) |
All recipients | 30,539 | 739,423 |
25,989 | Age: 0-11 | 141 |
5333 | 38,398 | Age: 12-17
| 104 | 3767 | 37,546 |
Age: 18-34 | 1110 | 27,222 |
25,821 | Age: 35-49 | 6262 |
135,545 | 22,756 | Age: 50-64
| 18,105 | 404,202 | 23,825 |
Age: ≥65 | 4817 | 163,355 |
38,571 | Sex: Male | 19,926 |
471,623 | 25,477 | Sex: Female
| 10,613 | 267,799 | 26,943 |
Race/ethnicity: White | 22,840 | 537,038 |
25,239 | Race/ethnicity: Black | 2500 |
72,942 | 31,719 | Race/ethnicity: Hispanic
| 3744 | 97,868 | 27,971 |
Race/ethnicity: Asian | 1173 | 24,351 |
21,903 | Race/ethnicity: Other/unknown | 282 |
7224 | 27,547 |
Diagnosis: Acute liver failure | 1214 | 23,910 |
20,618 | Diagnosis: HCV | 7654 |
194,031 | 27,484 | Diagnosis: ALD
| 5877 | 140,636 | 25,563 |
Diagnosis: Cholestatic disease | 3324 | 69,744 |
22,083 | Diagnosis: HCC | 3728 |
88,495 | 26,107 | Diagnosis: Other/unknown
| 8742 | 222,606 | 27,207 |
MELD: Status 1A/1B | 1329 | 26,452 |
20,820 | MELD: ≥ 35 | 3532 |
129,760 | 40,395 | MELD: 30-34
| 2919 | 84,984 | 31,960 |
MELD: 15-29 | 15,308 | 342,864 |
24,136 | MELD: < 15 | 1376 |
31,381 | 23,988 | MELD: Other/unknown
| 6075 | 123,982 | 21,394 |
Outcome: Alive with function | 28,414 | 606,745 |
22,144 | Outcome: Retransplant | 118 |
17,705 | 186,934 |
Outcome: Death with function | 2007 | 114,973 |
120,286 |
Table Econ 16 Average per person per year Medicare costs of intestinal transplant recipients during the year prior to transplant Costs among recipients with Medicare as primary payer at the time of transplant, 2009-2014. Pretransplant costs exclude the transplant hospitalization. Per person per year (PPPY) costs in $ units. Values for cells with 9 or fewer recipients are suppressed. IN, intestine without liver; IN-LI, intestine with liver; NEC, necrotizing enterocolitis; SGS, short-gut syndrome.
Subgroup | Patients, N | Pre-tx, 365 days | Pre-tx,90 days | Pre-tx, 30 days |
All recipients | 58 | 130,057 |
36,379 | 12,226 | Age: 0-11
| * | * | * | * |
Age: 12-17 | * | * |
* | * | Age: 18-34
| 11 | 142,159 | 35,590 |
14,081 | Age: 35-49 | 19 |
143,782 | 43,213 | 13,190 |
Age: 50-64 | 23 | 118,150 |
33,936 | 11,300 | Age: ≥65
| * | * | * | * |
Sex: Male | 23 | 108,991 |
31,973 | 12,423 | Sex: Female
| 35 | 143,900 | 39,275 |
12,096 | Race/ethnicity: White | 46 |
132,258 | 36,743 | 12,022 |
Race/ethnicity: Black | * | * |
* | * | Race/ethnicity: Hispanic
| * | * | * | * |
Race/ethnicity: Asian | * | * |
* | * | Race/ethnicity: Other/unknown
| * | * | * | * |
Diagnosis: NEC | * | * |
* | * | Diagnosis: Congenital SGS
| * | * | * | * |
Diagnosis: Other SGS | 45 | 131,919 |
35,093 | 12,330 |
Diagnosis: Pseudo-obstruction | * | * |
* | * | Diagnosis: Enteropathies
| * | * | * | * |
Diagnosis: Other/unknown | * | * |
* | * | Tx type: IN
| 44 | 145,386 | 41,467 |
12,959 | Tx type: IN-LI | 14 |
81,879 | 20,391 | 9919 |
Table Econ 17 Total and per person per year Medicare costs of intestine transplant recipients in year 1 posttransplant Costs for recipients with Medicare as primary payer at the time of transplant, 2008-2013. Year-1 costs include the transplant hospitalization. Costs incurred after transplant failure are excluded. Total costs are given in $1000 units and per person per year (PPPY) costs in $ units. Values for cells with 9 or fewer recipients are suppressed. GF, graft failure; IN, intestine without liver; IN-LI, intestine with liver; NEC, necrotizing enterocolitis; SGS, short-gut syndrome.
Subgroup | N | Total ($1000) | PPPY ($) |
All recipients | 71 | 22,374 |
366,144 | Age: 0-11 | * |
* | * | Age: 12-17
| * | * | * |
Age: 18-34 | 11 | 3896 |
470,910 | Age: 35-49 | 23 |
5823 | 271,426 | Age: 50-64
| 29 | 10,413 | 428,151 |
Age: ≥65 | * | * |
* | Sex: Male | 29 |
9050 | 345,876 | Sex: Female
| 42 | 13,324 | 381,320 |
Race/ethnicity: White | 59 | 18,208 |
355,926 | Race/ethnicity: Black | * |
* | * | Race/ethnicity: Hispanic
| * | * | * |
Race/ethnicity: Asian | * | * |
* | Race/ethnicity: Other/unknown | * |
* | * | Diagnosis: NEC
| * | * | * |
Diagnosis: Congenital SGS | * | * |
* | Diagnosis: Other SGS | 53 |
16,156 | 360,462 |
Diagnosis: Pseudo-obstruction | * | * |
* | Diagnosis: Enteropathies | * |
* | * | Diagnosis: Other/unknown
| 13 | 4822 | 396,043 |
Tx type: IN | 51 | 16,027 |
361,419 | Tx type: IN-LI | 20 |
6347 | 378,644 | Outcome: Alive with function
| 50 | 15,117 | 301,512 |
Outcome: GF/Retransplant | * | * |
* | Outcome: Death with function | 14 |
5821 | 1,041,527 |
Table Econ 18 Total and per person per year Medicare costs of intestine transplant recipients in year 2 posttransplant Costs for recipients with Medicare as primary payer at the time of transplant, 2008-2012. Year 2 is from day 366 to day 730 posttransplant. Costs incurred after transplant failure are excluded. Total costs are given in $1000 units and per person per year (PPPY) costs in $ units. Values for cells with 9 or fewer recipients are suppressed. GF, graft failure; IN, intestine without liver; IN-LI, intestine with liver; NEC, necrotizing enterocolitis; SGS, short-gut syndrome.
Subgroup | N | Total ($1000) | PPPY ($) |
All recipients | 44 | 4123 |
104,729 | Age: 0-11 | * |
* | * | Age: 12-17
| * | * | * |
Age: 18-34 | * | * |
* | Age: 35-49 | 18 |
1681 | 102,925 | Age: 50-64
| 17 | 1285 | 85,774 |
Age: ≥65 | * | * |
* | Sex: Male | 18 |
856 | 54,627 | Sex: Female
| 26 | 3267 | 137,869 |
Race/ethnicity: White | 37 | 3600 |
110,687 | Race/ethnicity: Black | * |
* | * | Race/ethnicity: Hispanic
| * | * | * |
Race/ethnicity: Asian | * | * |
* | Race/ethnicity: Other/unknown | * |
* | * | Diagnosis: NEC
| * | * | * |
Diagnosis: Congenital SGS | * | * |
* | Diagnosis: Other SGS | 33 |
2880 | 100,256 |
Diagnosis: Pseudo-obstruction | * | * |
* | Diagnosis: Enteropathies | * |
* | * | Diagnosis: Other/unknown
| 10 | 1022 | 106,091 |
Tx type: IN | 31 | 3003 |
112,357 | Tx type: IN-LI | 13 |
1120 | 88,606 | Outcome: Alive with function
| 34 | 3009 | 88,260 |
Outcome: GF/Retransplant | * | * |
* | Outcome: Death with function | * |
* | * |
Table Econ 19 Total and per person per year (PPPY) calendar-year Medicare costs of intestine transplant recipients, 2013 Costs paid by Medicare in 2013 for recipients alive with graft function in 2013, regardless of Medicare eligibility at the time of transplant. Costs incurred after transplant failure are excluded. Total costs are given in $1000 units and per person per year (PPPY) costs in $ units. Values for cells with 9 or fewer recipients are suppressed. GF, graft failure; IN, intestine without liver; IN-LI, intestine with liver; NEC, necrotizing enterocolitis; SGS, short-gut syndrome.
Subgroup | N | Total ($1000) | PPPY ($) |
All recipients | 276 | 15,108 |
59,784 | Age: 0-11 | * |
* | * | Age: 12-17
| * | * | * |
Age: 18-34 | 75 | 5206 |
72,158 | Age: 35-49 | 103 |
4461 | 47,534 | Age: 50-64
| 79 | 4390 | 64,237 |
Age: ≥65 | * | * |
* | Sex: Male | 118 |
5232 | 49,870 | Sex: Female
| 158 | 9875 | 66,822 |
Race/ethnicity: White | 228 | 12,250 |
58,799 | Race/ethnicity: Black | 27 |
1529 | 60,421 | Race/ethnicity: Hispanic
| 16 | 735 | 52,252 |
Race/ethnicity: Asian | * | * |
* | Race/ethnicity: Other/unknown | * |
* | * | Diagnosis: NEC
| * | * | * |
Diagnosis: Congenital SGS | * | * |
* | Diagnosis: Other SGS | 197 |
9971 | 55,320 | Diagnosis: Pseudo-obstruction
| 27 | 1671 | 66,186 |
Diagnosis: Enteropathies | * | * |
* | Diagnosis: Other/unknown | 44 |
2747 | 68,444 | Tx type: IN
| 184 | 11,063 | 66,152 |
Tx type: IN-LI | 92 | 4045 |
47,325 | Outcome: Alive with function | 240 |
10,606 | 46,228 | Outcome: GF/Retransplant
| 14 | 2490 | 214,247 |
Outcome: Death with function | 22 | 2011 |
172,709 |
Table Econ 20 Total and per person per year (PPPY) calendar-year Medicare costs of intestine transplant recipients, 2014 Costs paid by Medicare in 2014 for recipients alive with graft function in 2014, regardless of Medicare eligibility at the time of transplant. Costs incurred after transplant failure are excluded. Total costs are given in $1000 units and per person per year (PPPY) costs in $ units. Values for cells with 9 or fewer recipients are suppressed. GF, graft failure; IN, intestine without liver; IN-LI, intestine with liver; NEC, necrotizing enterocolitis; SGS, short-gut syndrome.
Subgroup | N | Total ($1000) | PPPY ($) |
All recipients | 279 | 14,867 |
58,649 | Age: 0-11 | * |
* | * | Age: 12-17
| * | * | * |
Age: 18-34 | 69 | 3831 |
59,724 | Age: 35-49 | 107 |
4646 | 46,366 | Age: 50-64
| 85 | 5286 | 73,139 |
Age: ≥65 | * | * |
* | Sex: Male | 118 |
5229 | 50,192 | Sex: Female
| 161 | 9638 | 64,551 |
Race/ethnicity: White | 225 | 12,066 |
59,417 | Race/ethnicity: Black | 32 |
1834 | 60,214 | Race/ethnicity: Hispanic
| 18 | 736 | 44,554 |
Race/ethnicity: Asian | * | * |
* | Race/ethnicity: Other/unknown | * |
* | * | Diagnosis: NEC
| * | * | * |
Diagnosis: Congenital SGS | * | * |
* | Diagnosis: Other SGS | 200 |
10,427 | 57,819 |
Diagnosis: Pseudo-obstruction | 25 | 1568 |
62,986 | Diagnosis: Enteropathies | * |
* | * | Diagnosis: Other/unknown
| 46 | 2641 | 64,057 |
Tx type: IN | 172 | 9214 |
58,909 | Tx type: IN-LI | 107 |
5653 | 58,230 | Outcome: Alive with function
| 238 | 10,244 | 44,305 |
Outcome: GF/Retransplant | * | * |
* | Outcome: Death with function | 32 |
2845 | 189,945 |
Table Econ 21 Average per person per year Medicare costs of heart transplant recipients during the year prior to transplant Costs among recipients with Medicare as primary payer at the time of transplant, 2009-2014. Pretransplant costs exclude the transplant hospitalization. Per person per year (PPPY) costs in $ units. Values for cells with 9 or fewer recipients are suppressed. CAD, coronary artery disease.
Subgroup | Patients, N | Pre-tx, 365 days | Pre-tx,90 days | Pre-tx, 30 days |
All recipients | 2675 | 111,899 |
26,921 | 7195 | Age: 0-11
| * | * | * | * |
Age: 12-17 | * | * |
* | * | Age: 18-34
| 128 | 107,087 | 30,180 |
7539 | Age: 35-49 | 427 |
112,105 | 27,834 | 6918 |
Age: 50-64 | 1108 | 113,901 |
28,084 | 7287 | Age: ≥65
| 1012 | 110,231 | 24,844 |
7167 | Sex: Male | 2049 |
116,201 | 27,264 | 7020 |
Sex: Female | 626 | 97,833 |
25,801 | 7766 | Race/ethnicity: White
| 1817 | 108,920 | 25,664 |
7004 | Race/ethnicity: Black | 593 |
118,733 | 29,550 | 7668 |
Race/ethnicity: Hispanic | 182 | 124,322 |
32,001 | 7876 | Race/ethnicity: Asian
| 62 | 96,188 | 23,710 |
6805 | Race/ethnicity: Other/unknown | 21 |
115,947 | 26,981 | 5590 |
Diagnosis: CAD | 1225 | 116,508 |
25,457 | 7093 | Diagnosis: Cardiomyopathy
| 1294 | 111,203 | 28,421 |
7283 | Diagnosis: Congenital | 54 |
65,516 | 25,925 | 7947 |
Diagnosis: Valvular | 57 | 77,124 |
21,557 | 7236 | Diagnosis: Other/unknown
| 45 | 106,667 | 31,636 |
6468 |
Table Econ 22 Total and per person per year Medicare costs among heart transplant recipients in year 1 posttransplant Costs among recipients with Medicare as primary payer at the time of transplant, 2008-2013. Year-1 costs include the transplant hospitalization. Costs incurred after a transplant failure are excluded. Total costs are given in $1000 units and per person per year (PPPY) costs in $ units. Values for cells with 9 or fewer recipients are suppressed. CAD, coronary artery disease.
Subgroup | N | Total ($1000) | PPPY ($) |
All recipients | 3135 | 875,144 |
304,692 | Age: 0-11 | * |
* | * | Age: 12-17
| * | * | * |
Age: 18-34 | 157 | 45,028 |
304,807 | Age: 35-49 | 511 |
149,806 | 317,076 | Age: 50-64
| 1315 | 362,104 | 298,807 |
Age: ≥65 | 1150 | 316,459 |
304,815 | Sex: Male | 2391 |
666,950 | 303,505 | Sex: Female
| 744 | 208,194 | 308,557 |
Race/ethnicity: White | 2127 | 589,049 |
299,931 | Race/ethnicity: Black | 688 |
193,072 | 313,612 | Race/ethnicity: Hispanic
| 225 | 63,973 | 314,656 |
Race/ethnicity: Asian | 70 | 22,175 |
332,017 | Race/ethnicity: Other/unknown | 25 |
6876 | 305,079 | Diagnosis: CAD
| 1441 | 398,431 | 303,754 |
Diagnosis: Cardiomyopathy | 1517 | 420,588 |
299,987 | Diagnosis: Congenital | 65 |
21,971 | 388,841 | Diagnosis: Valvular
| 62 | 18,435 | 323,783 |
Diagnosis: Other/unknown | 50 | 15,719 |
348,771 | Outcome: Alive with function | 2763 |
752,568 | 271,629 | Outcome: Retransplant
| * | * | * |
Outcome: Death with function | 368 | 121,500 |
1,219,640 |
Table Econ 23 Total and per person per year Medicare costs among heart transplant recipients in year 2 posttransplant Costs among recipients with Medicare as primary payer at the time of transplant, 2008-2012. Year 2 is from day 366 to day 730 posttransplant. Costs incurred after a transplant failure are excluded. Total costs are given in $1000 units and per person per year (PPPY) costs in $ units. Values for cells with 9 or fewer recipients are suppressed. CAD, coronary artery disease.
Subgroup | N | Total ($1000) | PPPY ($) |
All recipients | 2223 | 77,972 |
35,825 | Age: 0-11 | * |
* | * | Age: 12-17
| * | * | * |
Age: 18-34 | 116 | 4241 |
37,467 | Age: 35-49 | 367 |
15,067 | 42,424 | Age: 50-64
| 959 | 33,660 | 35,925 |
Age: ≥65 | 779 | 24,879 |
32,338 | Sex: Male | 1697 |
58,276 | 35,052 | Sex: Female
| 526 | 19,696 | 38,330 |
Race/ethnicity: White | 1529 | 53,669 |
35,893 | Race/ethnicity: Black | 465 |
16,829 | 36,785 | Race/ethnicity: Hispanic
| 163 | 5460 | 34,154 |
Race/ethnicity: Asian | 49 | 1402 |
29,790 | Race/ethnicity: Other/unknown | 17 |
612 | 36,503 | Diagnosis: CAD
| 1032 | 36,778 | 36,374 |
Diagnosis: Cardiomyopathy | 1071 | 36,868 |
35,136 | Diagnosis: Congenital | 45 |
1634 | 37,825 | Diagnosis: Valvular
| 43 | 972 | 22,538 |
Diagnosis: Other/unknown | 32 | 1721 |
57,828 | Outcome: Alive with function | 2119 |
68,663 | 32,315 | Outcome: Retransplant
| * | * | * |
Outcome: Death with function | 97 | 7064 |
157,305 |
Table Econ 24 Total and per person per year (PPPY) calendar-year Medicare costs of heart transplant recipients, 2013 Costs paid by Medicare in 2013 for recipients alive with graft function in 2013, regardless of Medicare eligibility at the time of transplant. Costs incurred after transplant failure are excluded. Total costs are given in $1000 units and per person per year (PPPY) costs in $ units. Values for cells with 9 or fewer recipients are suppressed. CAD, coronary artery disease.
Subgroup | N | Total ($1000) | PPPY ($) |
All recipients | 13,735 | 463,976 |
36,329 | Age: 0-11 | 54 |
1833 | 35,001 | Age: 12-17
| 54 | 1184 | 22,263 |
Age: 18-34 | 823 | 28,002 |
35,567 | Age: 35-49 | 2894 |
88,874 | 32,671 | Age: 50-64
| 7707 | 233,350 | 32,376 |
Age: ≥65 | 2203 | 110,733 |
56,758 | Sex: Male | 10,805 |
358,681 | 35,745 | Sex: Female
| 2930 | 105,295 | 38,471 |
Race/ethnicity: White | 10,462 | 335,053 |
34,415 | Race/ethnicity: Black | 2101 |
89,982 | 46,353 | Race/ethnicity: Hispanic
| 802 | 24,800 | 32,912 |
Race/ethnicity: Asian | 277 | 11,266 |
43,952 | Race/ethnicity: Other/unknown | 93 |
2875 | 34,020 | Diagnosis: CAD
| 6424 | 214,912 | 36,168 |
Diagnosis: Cardiomyopathy | 6478 | 221,240 |
36,577 | Diagnosis: Congenital | 307 |
9209 | 31,527 | Diagnosis: Valvular
| 327 | 10,154 | 33,740 |
Diagnosis: Other/unknown | 199 | 8460 |
45,062 | Outcome: Alive with function
| 12,732 | 395,412 | 32,207 |
Outcome: Retransplant | 32 | 4675 |
157,719 | Outcome: Death with function | 971 |
63,889 | 137,440 |
Table Econ 25 Total and per person per year (PPPY) calendar-year Medicare costs of heart transplant recipients, 2014 Costs paid by Medicare in 2014 for recipients alive with graft function in 2014, regardless of Medicare eligibility at the time of transplant. Costs incurred after transplant failure are excluded. Total costs are given in $1000 units and per person per year (PPPY) costs in $ units. Values for cells with 9 or fewer recipients are suppressed. CAD, coronary artery disease.
Subgroup | N | Total ($1000) | PPPY ($) |
All recipients | 14,113 | 485,497 |
37,171 | Age: 0-11 | 56 |
2205 | 40,392 | Age: 12-17
| 60 | 2028 | 35,071 |
Age: 18-34 | 868 | 27,256 |
33,348 | Age: 35-49 | 2923 |
90,680 | 33,059 | Age: 50-64
| 7773 | 236,107 | 32,640 |
Age: ≥65 | 2433 | 127,221 |
59,039 | Sex: Male | 11,024 |
371,641 | 36,449 | Sex: Female
| 3089 | 113,856 | 39,741 |
Race/ethnicity: White | 10,601 | 338,595 |
34,422 | Race/ethnicity: Black | 2266 |
100,434 | 48,467 | Race/ethnicity: Hispanic
| 863 | 31,863 | 40,135 |
Race/ethnicity: Asian | 294 | 11,014 |
39,936 | Race/ethnicity: Other/unknown | 89 |
3590 | 43,431 | Diagnosis: CAD
| 6441 | 217,022 | 36,571 |
Diagnosis: Cardiomyopathy | 6792 | 239,912 |
38,068 | Diagnosis: Congenital | 332 |
10,693 | 34,297 | Diagnosis: Valvular
| 339 | 10,486 | 33,136 |
Diagnosis: Other/unknown | 209 | 7384 |
37,570 | Outcome: Alive with function
| 13,027 | 409,661 | 32,651 |
Outcome: Retransplant | 26 | 3241 |
130,117 | Outcome: Death with function | 1060 |
72,595 | 148,285 |
Table Econ 26 Average per person per year Medicare costs of lung transplant recipients during the year prior to transplant Costs among recipients with Medicare as primary payer at the time of transplant, 2009-2014. Pretransplant costs exclude the transplant hospitalization. Per person per year (PPPY) costs in $ units. Values for cells with 9 or fewer recipients are suppressed. A, obstructive lung disease; B, pulmonary vascular disease; C, cystic fibrosis; D, restrictive lung disease; LAS, lung allocation score.
Subgroup | Patients, N | Pre-tx, 365 days | Pre-tx,90 days | Pre-tx, 30 days |
All recipients | 2635 | 32,201 |
10,684 | 3694 | Age: 0-11
| * | * | * | * |
Age: 12-17 | * | * |
* | * | Age: 18-34
| 177 | 94,774 | 29,910 |
8148 | Age: 35-49 | 240 |
56,319 | 17,548 | 5542 |
Age: 50-64 | 862 | 29,318 |
9594 | 3544 | Age: ≥65
| 1356 | 21,812 | 7709 |
2882 | Sex: Male | 1605 |
29,103 | 10,084 | 3684 |
Sex: Female | 1030 | 37,062 |
11,630 | 3711 | Race/ethnicity: White
| 2265 | 31,543 | 10,383 |
3679 | Race/ethnicity: Black | 208 |
35,413 | 12,111 | 3406 |
Race/ethnicity: Hispanic | 116 | 40,855 |
13,268 | 3946 | Race/ethnicity: Asian
| 30 | 25,886 | 10,584 |
5197 | Race/ethnicity: Other/unknown | 16 |
32,157 | 16,363 | 4974 |
Diagnosis group: A | 953 | 23,206 |
7129 | 2517 | Diagnosis group: B
| 100 | 100,300 | 28,446 |
5224 | Diagnosis group: C | 202 |
90,872 | 27,112 | 8329 |
Diagnosis group: D | 1380 | 25,132 |
9493 | 3719 | Diagnosis group: Other/unknown
| * | * | * | * |
LAS: <30 | * | * |
* | * | LAS: 30-< 35
| 727 | 23,342 | 6534 |
2093 | LAS: 35-< 40 | 587 |
32,293 | 9626 | 3215 |
LAS: 40-< 45 | 666 | 34,563 |
10,633 | 3159 | LAS: 45-< 50
| 258 | 32,564 | 12,299 |
4358 | LAS: 50-< 60 | 393 |
44,631 | 19,154 | 7837 |
LAS: ≥ 60 | * | * |
* | * |
Table Econ 27 Total and per person per year Medicare costs of lung transplant recipients in year 1 posttransplant Costs for recipients with Medicare as primary payer at the time of transplant, 2008-2013. Year-1 costs include the transplant hospitalization. Costs incurred after transplant failure are excluded. Total costs are given in $1000 units and per person per year (PPPY) costs in $ units. Values for cells with 9 or fewer recipients are suppressed. A, obstructive lung disease; B, pulmonary vascular disease; C, cystic fibrosis; D, restrictive lung disease; LAS, lung allocation score.
Subgroup | N | Total ($1000) | PPPY ($) |
All recipients | 3118 | 674,353 |
238,764 | Age: 0-11 | * |
* | * | Age: 12-17
| * | * | * |
Age: 18-34 | 215 | 50,382 |
254,453 | Age: 35-49 | 289 |
67,999 | 259,184 | Age: 50-64
| 1052 | 214,650 | 223,776 |
Age: ≥65 | 1562 | 341,322 |
242,973 | Sex: Male | 1907 |
413,534 | 241,740 | Sex: Female
| 1211 | 260,819 | 234,192 |
Race/ethnicity: White | 2673 | 574,062 |
235,785 | Race/ethnicity: Black | 253 |
56,210 | 253,987 | Race/ethnicity: Hispanic
| 137 | 31,449 | 268,058 |
Race/ethnicity: Asian | 35 | 8587 |
261,079 | Race/ethnicity: Other/unknown | 20 |
4045 | 223,003 | Diagnosis group: A
| 1162 | 226,914 | 212,275 |
Diagnosis group: B | 119 | 30,854 |
292,538 | Diagnosis group: C | 237 |
52,592 | 234,911 | Diagnosis group: D
| 1600 | 363,992 | 255,248 |
Diagnosis group: Other/unknown | * | * |
* | LAS: <30 | * |
* | * | LAS: 30-< 35
| 880 | 168,722 | 209,087 |
LAS: 35-< 40 | 706 | 148,294 |
227,633 | LAS: 40-< 45 | 779 |
169,791 | 241,691 | LAS: 45-< 50
| 302 | 67,234 | 254,539 |
LAS: 50-< 60 | 442 | 118,611 |
303,865 | LAS: ≥ 60 | * |
* | * | Outcome: Alive with function
| 2596 | 509,622 | 195,774 |
Outcome: Retransplant | 52 | 19,894 |
642,357 | Outcome: Death with function | 470 |
144,837 | 761,235 |
Table Econ 28 Total and per person per year Medicare costs of lung transplant recipients in year 2 posttransplant Costs for recipients with Medicare as primary payer at the time of transplant, 2008-2012. Year 2 is from day 366 to day 730 days posttransplant. Costs incurred after transplant failure are excluded. Total costs are given in $1000 units and per person per year (PPPY) costs in $ units. Values for cells with 9 or fewer recipients are suppressed. A, obstructive lung disease; B, pulmonary vascular disease; C, cystic fibrosis; D, restrictive lung disease; LAS, lung allocation score.
Subgroup | N | Total ($1000) | PPPY ($) |
All recipients | 2092 | 102,127 |
51,757 | Age: 0-11 | * |
* | * | Age: 12-17
| * | * | * |
Age: 18-34 | 148 | 8311 |
58,708 | Age: 35-49 | 212 |
10,107 | 50,461 | Age: 50-64
| 726 | 35,235 | 50,968 |
Age: ≥65 | 1006 | 48,474 |
51,567 | Sex: Male | 1244 |
58,468 | 49,993 | Sex: Female
| 848 | 43,659 | 54,325 |
Race/ethnicity: White | 1815 | 89,274 |
52,052 | Race/ethnicity: Black | 153 |
6470 | 46,201 | Race/ethnicity: Hispanic
| 82 | 4524 | 57,240 |
Race/ethnicity: Asian | 28 | 1222 |
46,884 | Race/ethnicity: Other/unknown | 14 |
638 | 49,195 | Diagnosis group: A
| 827 | 41,213 | 52,352 |
Diagnosis group: B | 85 | 4626 |
58,383 | Diagnosis group: C | 175 |
9742 | 57,455 | Diagnosis group: D
| 1005 | 46,546 | 49,667 |
Diagnosis group: Other/unknown | * | * |
* | LAS: <30 | * |
* | * | LAS: 30-< 35
| 622 | 30,881 | 52,126 |
LAS: 35-< 40 | 492 | 24,651 |
52,795 | LAS: 40-< 45 | 518 |
23,500 | 48,433 | LAS: 45-< 50
| 196 | 9957 | 54,280 |
LAS: 50-< 60 | 257 | 12,976 |
54,471 | LAS: ≥ 60 | * |
* | * | Outcome: Alive with function
| 1835 | 74,716 | 40,606 |
Outcome: Retransplant | 24 | 4961 |
261,330 | Outcome: Death with function | 233 |
22,450 | 196,614 |
Table Econ 29 Total and per person per year (PPPY) calendar-year Medicare costs of lung transplant recipients, 2013 Costs paid by Medicare in 2013 for recipients alive with graft function in 2013, regardless of Medicare eligibility at the time of transplant. Costs incurred after transplant failure are excluded. Total costs are given in $1000 units and per person per year (PPPY) costs in $ units. Values for cells with 9 or fewer recipients are suppressed. A, obstructive lung disease; B, pulmonary vascular disease; C, cystic fibrosis; D, restrictive lung disease; LAS, lung allocation score.
Subgroup | N | Total ($1000) | PPPY ($) |
All recipients | 6959 | 301,482 |
49,425 | Age: 0-11 | * |
* | * | Age: 12-17
| 12 | 487 | 46,057 |
Age: 18-34 | 582 | 28,415 |
53,274 | Age: 35-49 | 1091 |
37,409 | 37,212 | Age: 50-64
| 3519 | 124,943 | 39,718 |
Age: ≥65 | 1749 | 110,150 |
78,748 | Sex: Male | 4009 |
186,052 | 53,532 | Sex: Female
| 2950 | 115,430 | 43,987 |
Race/ethnicity: White | 5927 | 251,812 |
48,536 | Race/ethnicity: Black | 604 |
29,938 | 56,080 | Race/ethnicity: Hispanic
| 313 | 13,307 | 48,405 |
Race/ethnicity: Asian | 78 | 3749 |
53,154 | Race/ethnicity: Other/unknown | 37 |
2676 | 82,655 | Diagnosis group: A
| 2714 | 110,425 | 46,287 |
Diagnosis group: B | 322 | 12,179 |
41,669 | Diagnosis group: C | 651 |
26,179 | 43,922 | Diagnosis group: D
| 3228 | 151,687 | 54,524 |
Diagnosis group: Other/unknown | 44 | 1011 |
23,122 | LAS: <30 | 18 |
395 | 23,115 | LAS: 30-< 35
| 1656 | 74,447 | 51,828 |
LAS: 35-< 40 | 1277 | 54,293 |
48,792 | LAS: 40-< 45 | 1312 |
60,243 | 52,634 | LAS: 45-< 50
| 500 | 25,546 | 59,606 |
LAS: 50-< 60 | 829 | 48,541 |
70,427 | LAS: ≥ 60 | 1367 |
38,017 | 29,910 |
Outcome: Alive with function | 6114 | 230,332 |
40,456 | Outcome: Retransplant | 60 |
9728 | 205,450 | Outcome: Death with function
| 785 | 61,422 | 171,055 |
Table Econ 30 Total and per person per year (PPPY) calendar-year Medicare costs of lung transplant recipients, 2014 Costs paid by Medicare in 2014 for recipients alive with graft function in 2014, regardless of Medicare eligibility at the time of transplant. Costs incurred after transplant failure are excluded. Total costs are given in $1000 units and per person per year (PPPY) costs in $ units. Values for cells with 9 or fewer recipients are suppressed. A, obstructive lung disease; B, pulmonary vascular disease; C, cystic fibrosis; D, restrictive lung disease; LAS, lung allocation score.
Subgroup | N | Total ($1000) | PPPY ($) |
All recipients | 7339 | 308,609 |
47,614 | Age: 0-11 | * |
* | * | Age: 12-17
| 11 | 754 | 69,079 |
Age: 18-34 | 592 | 28,395 |
52,450 | Age: 35-49 | 1109 |
36,766 | 35,818 | Age: 50-64
| 3691 | 130,205 | 39,294 |
Age: ≥65 | 1930 | 112,275 |
70,919 | Sex: Male | 4255 |
182,519 | 49,041 | Sex: Female
| 3084 | 126,090 | 45,690 |
Race/ethnicity: White | 6248 | 261,222 |
47,459 | Race/ethnicity: Black | 617 |
27,952 | 50,238 | Race/ethnicity: Hispanic
| 345 | 13,726 | 45,440 |
Race/ethnicity: Asian | 94 | 3911 |
45,646 | Race/ethnicity: Other/unknown | 35 |
1798 | 54,310 | Diagnosis group: A
| 2731 | 103,549 | 42,564 |
Diagnosis group: B | 328 | 12,719 |
42,022 | Diagnosis group: C | 681 |
32,457 | 52,173 | Diagnosis group: D
| 3560 | 158,894 | 51,453 |
Diagnosis group: Other/unknown | 39 | 990 |
27,680 | LAS: <30 | 17 |
525 | 35,020 | LAS: 30-< 35
| 1723 | 70,778 | 46,218 |
LAS: 35-< 40 | 1346 | 54,401 |
45,939 | LAS: 40-< 45 | 1457 |
64,373 | 50,567 | LAS: 45-< 50
| 569 | 23,795 | 49,444 |
LAS: 50-< 60 | 1011 | 60,244 |
69,197 | LAS: ≥ 60 | 1216 |
34,493 | 30,634 |
Outcome: Alive with function | 6468 | 236,272 |
39,048 | Outcome: Retransplant | 61 |
11,196 | 214,452 |
Outcome: Death with function | 810 | 61,141 |
161,583 |
|